David T. Rubin to Hematologic Diseases
This is a "connection" page, showing publications David T. Rubin has written about Hematologic Diseases.
Connection Strength
0.398
-
Effect of adalimumab on clinical laboratory parameters in patients with Crohn's disease: results from the CHARM trial. Inflamm Bowel Dis. 2012 May; 18(5):818-25.
Score: 0.398
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.